Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

DMC recommends continuation of pivotal ThermoDox study

April 24, 2012

Discovery of clinical-stage c-Met inhibitor described

April 24, 2012

CHMP recommends approval of Jakavi

April 23, 2012

Novel products disclosed by Genentech and MRC Technology

April 23, 2012

CHMP confirms MAA opinion on Folotyn

April 23, 2012

Novel PI3Kbeta inhibitor shows potential to treat PTEN-deficient tumors

April 23, 2012

New BTK inhibitor shows promise to treat B-cell malignancies

April 23, 2012

Novel anticancer compounds patented by Sanofi

April 23, 2012

Aragon Pharmaceuticals discloses new estrogen receptor modulators

April 20, 2012

Novel candidate cancer therapies developed by Sanofi

April 20, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...